SI
CSTL icon

Stephens Inc’s Castle Biosciences CSTL Stock Holding History

Stephens Inc’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,122
Closed -$433K – 1329
2025
Q4 		$433K Hold
11,122
– – 0.01% 892
2025
Q3 		$253K Sell
11,122
-264
-2% -$5.36K ﹤0.01% 1121
2025
Q2 		$233K Sell
11,386
-2,253
-17% -$41.7K ﹤0.01% 1117
2025
Q1 		$273K Sell
13,639
-800
-6% -$19.8K ﹤0.01% 1026
2024
Q4 		$385K Sell
14,439
-656
-4% -$20K 0.01% 920
2024
Q3 		$431K Sell
15,095
-8,678
-37% -$221K 0.01% 895
2024
Q2 		$518K Sell
23,773
-10,961
-32% -$244K 0.01% 779
2024
Q1 		$769K Sell
34,734
-8,845
-20% -$192K 0.01% 653
2023
Q4 		$940K Sell
43,579
-53,372
-55% -$939K 0.02% 549
2023
Q3 		$1.64M Sell
96,951
-10,947
-10% -$191K 0.03% 417
2023
Q2 		$1.48M Buy
107,898
+32,879
+44% +$666K 0.03% 452
2023
Q1 		$1.7M Buy
75,019
+21,387
+40% +$523K 0.03% 425
2022
Q4 		$1.26M Buy
53,632
+8,857
+20% +$205K 0.03% 465
2022
Q3 		$1.17M Sell
44,775
-725
-2% -$20.3K 0.02% 488
2022
Q2 		$999K Buy
+45,500
New +$1.06M 0.02% 518

Other funds holding CSTL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Stephens Inc's CSTL Position: Q1 2026 in Review

Stephens Inc sold out of Castle Biosciences (CSTL) in Q1 2026, closing a stake of 11,122 shares — an estimated $433K sold.

Stephens Inc first reported a position in CSTL in Q2 2022 and held it in 15 quarters. The position peaked at $1.7M in Q1 2023. 186 funds tracked by Wall St. Rank hold CSTL as of Q1 2026.

  • Stephens Inc reported no remaining Castle Biosciences position as of Q1 2026 after selling out during the quarter.
  • Stephens Inc sold 11,122 Castle Biosciences shares in Q1 2026, an estimated $433K.
  • Stephens Inc first reported a position in Castle Biosciences in Q2 2022 and held it in 15 quarters.
  • Stephens Inc's Castle Biosciences position peaked at $1.7M in Q1 2023.
  • 186 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2026.

Based on Stephens Inc's 13F filing for Q1 2026, filed 28 Apr 2026.